Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Miquel

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Revista Espanola De Enfermedades Digestivas|March 4, 2011
Five-year follow-up of patients with chronic C hepatitis and sustained virological responseI Puig Del Castillo, M Miquel Planas, M Vergara Gómez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2022
ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with CholangiocarcinomaHelena Verdaguer, Tamara Saurí, Daniel Alejandro Acosta, et al.
Acta Dermato-Venereologica|November 20, 2023
Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi ConsensusJose J Pereyra-Rodriguez, Esther S Baldrich, Ricardo Ruiz-Villaverde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2024
Clinical Value of Liquid Biopsy in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma During Targeted TherapyAlberto González-Medina, Maria Vila-Casadesús, Marina Gomez-Rey, et al.
Journal of Pharmaceutical Sciences|May 23, 2023
Clustering of Tadalafil API Samples According to their Manufacturer in the Context of API Falsification DetectionE Deconinck, M Raimondo, A Borioni, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 10, 2020
Analysis of mismatch repair (MMR) proteins expression in a series of malignant pleural mesothelioma (MPM) patientsS Cedrés, S Ponce-Aix, P Iranzo, et al.
Journal of the National Cancer Institute|March 13, 2018
Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 MutationSusana Cedrés, Enriqueta Felip, Cristina Cruz, et al.
Nephron|November 27, 2025
Exercise Intervention in Patients with Metabolic Syndrome and Renal Disease: A Prospective Study (EXRED)Olav Rivero Martín, Raúl Morales Febles, Patricia I Delgado Mallén, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)A Martinez-Marti, E Felip, J Matito, et al.
Drug Testing and Analysis|June 24, 2025
SARMs, Metabolic Modulators and Growth Hormone Secretagogues in Suspected Illegal Medicines, Bought as Sport Performance Enhancers: A Retro- and Prospective Study Within the GEONM Mendoza Barrios, E Deconinck, C Vanhee, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Revista Espanola De Enfermedades Digestivas|March 4, 2011
Five-year follow-up of patients with chronic C hepatitis and sustained virological responseI Puig Del Castillo, M Miquel Planas, M Vergara Gómez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2022
ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with CholangiocarcinomaHelena Verdaguer, Tamara Saurí, Daniel Alejandro Acosta, et al.
Acta Dermato-Venereologica|November 20, 2023
Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi ConsensusJose J Pereyra-Rodriguez, Esther S Baldrich, Ricardo Ruiz-Villaverde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2024
Clinical Value of Liquid Biopsy in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma During Targeted TherapyAlberto González-Medina, Maria Vila-Casadesús, Marina Gomez-Rey, et al.
Journal of Pharmaceutical Sciences|May 23, 2023
Clustering of Tadalafil API Samples According to their Manufacturer in the Context of API Falsification DetectionE Deconinck, M Raimondo, A Borioni, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 10, 2020
Analysis of mismatch repair (MMR) proteins expression in a series of malignant pleural mesothelioma (MPM) patientsS Cedrés, S Ponce-Aix, P Iranzo, et al.
Journal of the National Cancer Institute|March 13, 2018
Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 MutationSusana Cedrés, Enriqueta Felip, Cristina Cruz, et al.
Nephron|November 27, 2025
Exercise Intervention in Patients with Metabolic Syndrome and Renal Disease: A Prospective Study (EXRED)Olav Rivero Martín, Raúl Morales Febles, Patricia I Delgado Mallén, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)A Martinez-Marti, E Felip, J Matito, et al.
Drug Testing and Analysis|June 24, 2025
SARMs, Metabolic Modulators and Growth Hormone Secretagogues in Suspected Illegal Medicines, Bought as Sport Performance Enhancers: A Retro- and Prospective Study Within the GEONM Mendoza Barrios, E Deconinck, C Vanhee, et al.
Pageof 9